NASDAQ:MCRB

Seres Therapeutics Stock Predictions

etoro logo Buy MCRB
*Your capital is at risk
$7.17
-0.160 (-2.18%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

MCRB Prediction Chart

MCRB Predictions History

Latest community submissions for MCRB.
Predictor Target Session Target Price Result Direction Accuracy Score
iHustle84 iHustle84 Pro
Oct 19, 2020 $35.89 +10.09% $32.60 X 89.91% 0
Elaine Jackson Elaine Jackson @ElaineJackson.175172
Oct 19, 2020 Bearish $32.60 X 1
JS JS Pro
Sep 23, 2020 $26.32 +3.34% $25.47 X 96.66% 1
iHustle84 iHustle84 Pro
Sep 23, 2020 $27.89 +9.50% $25.47 X 90.50% 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Aug 13, 2020 $23.91 -16.34% $28.58 X 83.66% 1
JS JS Pro
Aug 13, 2020 $25.91 -9.34% $28.58 X 90.66% 1
iHustle84 iHustle84 Pro
Aug 13, 2020 $24.67 -13.68% $28.58 X 86.32% 1
2poJeff 2poJeff Pro
Aug 13, 2020 $21.10 -26.17% $28.58 X 73.83% 1
May 22, 2020 Bearish $5.53 X 0
StockVader StockVader Merchant
Sep 21, 2016 $13.63 -5.08% $14.36 X 94.90% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MCRB with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SERES THERAPEUTICS
Seres Therapeutics
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-155, a cultivated bacteri...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE